4//SEC Filing
APPLIED GENETIC TECHNOLOGIES CORP 4
Accession 0001209191-14-077687
CIK 0001273636operating
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 2:54 PM ET
Size
11.5 KB
Accession
0001209191-14-077687
Insider Transaction Report
Form 4
Menichella Daniel L
V.P. & Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2014-12-22$4.90/sh+9,000$44,100→ 9,000 total - Sale
Common Stock
2014-12-22$20.83/sh−9,000$187,470→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-12-22−9,000→ 117,968 totalExercise: $4.90Exp: 2023-09-18→ Common Stock (9,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.6535 to $21.01, inclusive. The reporting person undertakes to provide Applied Genetic Technologies Corporation, any security holder in Applied Genetic Technologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The option, representing a right to purchase a total of 126,968 shares, became exercisable for 25% of the underlying shares on September 18, 2014, and thereafer becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option becoming exercisable for 100% of the underlying shares on the fourth anniversary of the date of grant.
Issuer
APPLIED GENETIC TECHNOLOGIES CORP
CIK 0001273636
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001273636
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 2:54 PM ET
- Size
- 11.5 KB